iCo’s oral Amphotericin B found to be effective against Leishmaniasis
The studies were undertaken at an independent research laboratory in the US with significant experience with visceral Leishmaniasis animal models. Dosages of 10mg/kg and 20mg/kg of iCo-009 were
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.